









|
Teva Pharmaceutical Industries Ltd.
Balance Sheet Data (in thousands)
| |
March 31 |
Dec. 31 |
| |
1999 |
1998 |
1998 |
| |
U.S. Dollars |
| |
(unaudited) |
(audited) |
| Assets |
|
|
|
| Current Assets |
|
|
|
| Cash and cash equivalents |
69,780 |
60,927 |
47,074 |
| Short-term investments |
2,100 |
4,643 |
2,148 |
| Accounts receivable: |
|
|
|
| Trade |
263,033 |
226,361 |
274,592 |
| Other |
87,907 |
56,610 |
99,182 |
| Inventories |
350,187 |
300,801 |
353,249 |
| Total current assets |
773,007 |
649,342 |
776,245 |
| investments and non-current receivables: |
31,839 |
25,203 |
32,566 |
| |
|
|
|
| property, plant and equipment: |
|
|
|
| Cost |
755,654 |
672,050 |
754,638 |
| Less Accumulated depreciation |
309,848 |
257,460 |
299,656 |
| |
445,806 |
414,590 |
454,982 |
| intangible assets, net |
167,809 |
80,315 |
172,205 |
| |
1,418,461 |
1,169,450 |
1,435,998 |
| liabilities and shareholders' equity |
|
|
|
| current liabilities |
|
|
|
| Short-term credit-mainly from banks |
319,067 |
219,298 |
324,534 |
| Accounts payable and accruals: |
|
|
|
| Trade |
93,542 |
109,957 |
123,743 |
| Other |
90,709 |
73,885 |
84,814 |
| Proposed Dividend |
5,126 |
5,235 |
4,554 |
| Total current liabilities |
508,444 |
408,375 |
537,645 |
| long-term liabilities: |
|
|
|
| Deferred income taxes |
31,114 |
12,543 |
33,172 |
| Accrued employee rights upon retirement,
net of amount funded |
3,878 |
4,477 |
3,895 |
| Loans and other liabilities |
201,302 |
113,070 |
201,699 |
| Total long-term liabilities |
236,294 |
130,090 |
238,766 |
| Total Liabilities |
744,738 |
538,465 |
776,411 |
| minority interest |
481 |
703 |
781 |
| shareholders' equity |
673,242 |
630,282 |
658,806 |
| |
1,418,461 |
1,169,450 |
1,435,998 |
|
|